Method Development and Validation of Amlodipine, Gliquidone and Pioglitazone: Application in the Analysis of Human Serum

References

• Tuomilehto, J., Rastenyte, D., Birkenhager, WH., Thijs, L., Antikainen, R., Bulpitt, CJ., Fletcher, AE., Forette, F., Goldhaber, A., Palatini, P., Sarti, C. and Fagard, R. (1999). Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N. Engl. J. Med 340: 677–684. doi: 10.1056/NEJM199903043400902
   PubMed Web of Science ®Google Scholar
• Hansson, L., Zanchetti, A., Carruthers, S.G., Dahlof, B., Elmfeldt, D., Julius, S., Menard, J., Rahn, KH., Wedel, H. and Westerling, S. (1998). Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment randomized trial, Lancet, 351: 1755–1762. doi: 10.1016/S0140-6736(98)04311-6
   PubMed Web of Science ®Google Scholar
• Schrier, RW., Estacio, RO., Esler, A., and Mehler, P. (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetics on albuminuria, retinopathy, and strokes. Kidney Int., 61: 1086–1097. doi: 10.1046/j.1523-1755.2002.00213.x
   PubMed Web of Science ®Google Scholar
• Bakris, G.L., Gaxiola, E., Messerli, F.H., Mancia, G., Erdine, S., Cooper, D.R. and Pepine, C.J., (2004) Clinical outcomes in the diabetic cohort of the International Verapamil SR-Trandolapril Study. Hypertension, 44: 643–648. doi: 10.1161/01.HYP.0000143851.23721.26
   PubMed Web of Science ®Google Scholar
• Hanaa, M., Abdel-Wadood, Niveen Mohamed, A. Ashraf Mahmoud, M. (2008). Validated spectrofluorometric methods for determination of amlodipine besylate in tablets, Spectrochimica Acta Part A 70: 564–570. doi: 10.1016/j.saa.2007.07.055
   PubMed Web of Science ®Google Scholar
• Malaisse, W.J. (2006). Gliquidone contributes to improvement of type 2 diabetes mellitus management: a review of pharmacokinetic and clinical trial data, Drugs R.D. 7: 331–337. doi: 10.2165/00126839-200607060-00002
   PubMedGoogle Scholar
• Lee, K.W., Ku, Y.H., Kim, M., Ahn, B.Y., Chung, S.S., Park, K.S. (2011). Effects of Sulfonylureas on peroxisome proliferator-activated receptor ã activity and on glucose uptake by thiazolidinediones, Diabetes. Metab. J. 35: 340–347. doi: 10.4093/dmj.2011.35.4.340
   Google Scholar
• Lincoff, A.M., Wolski, K., Nicholls, S.J., Nissen, S.E. (2007). Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus, A meta-analysis of randomized trials, JAMA. 298: 1180–1188. doi: 10.1001/jama.298.10.1180
   PubMed Web of Science ®Google Scholar
• Erdmann, E. and Wilcox, R.G. (2008). Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure, Eur. Heart. J. 29(1): 12–20. doi: 10.1093/eurheartj/ehm529
   PubMed Web of Science ®Google Scholar
• American Diabetes. (2004). Association, Hypertension management in adults with diabetes, Diabetes Care, January vol. 27 no. suppl 1 s65–s67.
   Google Scholar
• National Kidney Foundation: Guideline 8: (2004). Pharmacological therapy: diabetic kidney disease, Am J. Kidney. Dis., 43(1): S142–S159.
   Google Scholar
• Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L.Jr., Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T.Jr. and Roccella, E.J. (2003). Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42: 1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2
   PubMed Web of Science ®Google Scholar
• Majernick, T.G., Zacker, C., Madden, N.A., Belletti, D.A. and Arcona, S. (2004). Correlates of hypertension control in a primary care setting. Am. J. Hypertens. 17: 915–920. doi: 10.1016/j.amjhyper.2004.05.016
   PubMed Web of Science ®Google Scholar
• Scheen, A.J. (2005). Drug Interactions of Clinical Importance with Antihyperglycaemic Agents: An Update. Review Article, Drug Safety, 28: 601–631. doi: 10.2165/00002018-200528070-00004
   PubMed Web of Science ®Google Scholar
• Steven, B.L., Stephanie, T. (2003). Combination Medications in Diabetes Care: An Opportunity That Merits More Attention, Clinical Diabetes, 21: 175–178. doi: 10.2337/diaclin.21.4.175
   Google Scholar
• Tatar, S, Atmaca, S. (2001). Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B. Biomed. Sci. Appl., 758(2): 305–310. doi: 10.1016/S0378-4347(01)00197-9
   PubMed Web of Science ®Google Scholar
• Bahrami, G, Mirzaeei, SH. (2004). Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies. J. Pharm. Biomed Anal., 36(1): 163–168. doi: 10.1016/j.jpba.2004.05.016
   PubMed Web of Science ®Google Scholar
• Zarghi, A., Foroutan, S.M., Shafaati, A., Khoddam, A. (2005). Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies. Farmaco. 60(9): 789–792.
   Google Scholar
• Malesuik, M.D., Cardoso, S.G., Bajerski, L., Lanzanova, F.A. (2006). Determination of amlodipine in pharmaceutical dosage forms by liquid chromatography and ultraviolet spectrophotometry. J. A.O.A.C Int., 89(2): 359–364.
   Google Scholar
• Nirogi, R.V., Kandikere, V.N., Mudigonda, K., Shukla, M., Maurya, S. (2006). Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma. Biomed Chromatogr., 20(9): 833–842. doi: 10.1002/bmc.600
   PubMed Web of Science ®Google Scholar
• Bhatt, J., Singh, S., Subbaiah, G., Shah, B., Kambli, S., Ameta, S. (2007). A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of amlodipine in human plasma. Biomed Chromatogr. 21(2):, 169–175. doi: 10.1002/bmc.730
   PubMed Web of Science ®Google Scholar
• Mohammadi, A., Rezanour, N., Ansari Dogaheh, M., Ghorbani Bidkorbeh, F., Hashem, M ., Walker R.B. (2007). A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci., 846(1-2): 215–221 doi: 10.1016/j.jchromb.2006.09.007
   PubMed Web of Science ®Google Scholar
• Dongre, V.G., Shah, S.B., Karmuse, P.P., Phadke, M., Jadhav, V.K. (2008) Simultaneous determination of metoprolol succinate and amlodipine besylate in pharmaceutical dosage form by HPLC. J. Pharm. Biomed. Anal., 46(3): 583–586. doi: 10.1016/j.jpba.2007.11.006
   PubMed Web of Science ®Google Scholar
• Arayne, M.S., Sultana, N., Bahadur, S.S., Nawaz, M. (2012). Simultaneous determination of amlodipine with H1-receptor antagonists by reversed phase high performance liquid chromatography and application to interaction studies, American Journal of Analytical Chemistry, 3: 632–637. doi: 10.4236/ajac.2012.39082
   Google Scholar
• Arayne, M.S., Sultana, N., Mirza, A.Z., Siddiqui, F.A. (2010). Validated RP-HPLC method for quantitation of gliquidone in pharmaceutical formulation and human serum, Journal of Chilean Chemical Society, 55: 156–158.
   Web of Science ®Google Scholar
• Siddiqui, F.A., Sher, N., Shamshad, H., Shafi, N. and Mirza, A.Z. (2013). Analysis of metformin, glimepiride and pioglitazone in human serum and its application to pharmacokinetics, Analytical Methods, 5: 5096–5104. doi: 10.1039/c3ay40884a
   Web of Science ®Google Scholar
• Arayne, M.S., Sultana, N., Mirza, A.Z. and Shamshad, H. (2010). High-performance liquid chromatographic analysis of pioglitazone, gliquidone, rosuvastatin and simvastatin in formulations and human serum, Chinese Journal of Chemistry, 28: 1998–2002. doi: 10.1002/cjoc.201090333
   Web of Science ®Google Scholar
• Arayne, M.S., Sultana, N., Mirza, A.Z. and Siddiqui, F.A. (2010). Simultaneous determination of gliquidone, fexofenadine, buclizine and levocetirizine in dosage formulation and human serum by RP-HPLC. Journal of Chromatographic Sciences, 48: 382–385. doi: 10.1093/chromsci/48.5.382
   PubMed Web of Science ®Google Scholar
• Arayne, M.S, Sultana, N., Mirza, A.Z. (2011). Simultaneous determination of gliquidone, pioglitazone hydrochloride and verapamil in formulation and human serum by RP-HPLC, Journal of Chromatographic Sciences, 49: 114–117. doi: 10.1093/chrsci/49.2.114
   PubMed Web of Science ®Google Scholar
• Mirza, A.Z., Arayne, M.S., Sultana, N. (2013). RP-LC method for the simultaneous determination of gliquidone, pioglitazone hydrochloride and atorvastatin in formulations and human serum, The Journal of AOAC INTERNATIONAL, 96: 56–59. doi: 10.5740/jaoacint.10-441
   PubMed Web of Science ®Google Scholar
• ICH, Topic Q2(R1). (2005).Validation of Analytical Procedures: Methodology.
   Google Scholar
• Guidance for Industry. (2001). Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
   Google Scholar
• Emami, J., Ghassami, N., Hamishehkar, H. (2006). A rapid and sensitive hplc method for the analysis of metronidazole in human plasma: application to single dose pharmacokinetic and bioequivalence studies, Daru, 14: 15–21.
   Google Scholar
• Cevasco, G., Piatek, A.M, Thea, S. (2014). HPLC determination of D-3-hydroxybutyric acid by derivatization with a benzofurazan reagent and fluorescent detection: Application in the analysis of human plasma, Clinica Chimica Acta 429: 90–95 doi: 10.1016/j.cca.2013.11.030
   PubMed Web of Science ®Google Scholar